H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census population 159,732. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Paterson clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Paterson storefront.
Growth Factor Therapy for Tissue Repair in Paterson, NJ for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 20% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JL-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Paterson we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 16.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 16.1% of adults — 4.1 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Paterson trial.
No. They are B2B distribution pages for licensed providers. Patients in Paterson should speak with their clinician, not use a distributor URL as care instructions.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). New Jersey Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Novitas Solutions CTP articles. Mixing those codes is a billing error.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Paterson tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Paterson, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Paterson is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Paterson — 4.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Paterson. Useful for joint-program math; still needs a diagnosis and privileging.
No Paterson storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.